Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2005
10/20/2005CA2561686A1 Humanized anti-tgf-beta antibodies
10/20/2005CA2561276A1 Irta-5 antibodies and their uses
10/20/2005CA2561164A1 Steroid sparing agents and their use
10/20/2005CA2560941A1 Compositions as adjuvants to improve immune responses to vaccines and methods of use
10/20/2005CA2560937A1 Compositions and methods for inducing anti-tumor immunity
10/20/2005CA2559910A1 Compositions of polypeptides specific to pathogenic strains and their use as vaccines and in immunotherapy
10/19/2005EP1586655A2 Improved methods for transfecting T cells
10/19/2005EP1586643A2 Polypeptides and nucleic acids encoding same
10/19/2005EP1586642A2 Tumor supressor genes, proteins encoded thereby and use of said genes and proteins
10/19/2005EP1586641A2 Compounds for the treatment of hypercalcemia and hypocalcemia
10/19/2005EP1586638A1 Monoclonal antibody for immunologically analyzing or concentrating endocrine disruptor or its degradation product and utilization of the same
10/19/2005EP1586635A1 Fusion proteins with parts of immunoglobulins, their production and use
10/19/2005EP1586587A1 Compositions and methods for detecting angiogenesis
10/19/2005EP1586581A2 Non-Mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
10/19/2005EP1586333A2 Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/Tie receptor function and their use (II)
10/19/2005EP1586325A1 Drugs containing galectin 9
10/19/2005EP1586284A1 Induction of immunological tolerance
10/19/2005EP1585984A2 Diagnostic methods for protein profiling
10/19/2005EP1585966A2 METHODS FOR IDENTIFYING TUMORS THAT ARE RESPONSIVE TO TREATMENT WITH ANTI-ErbB2 ANTIBODIES
10/19/2005EP1585954A2 Mammalian sweet and amino acid heterodimeric taste receptors
10/19/2005EP1585770A2 Recognition molecules for the treatment and detection of tumours
10/19/2005EP1585769A2 Neuropilin-1 inhibitors
10/19/2005EP1585768A2 Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
10/19/2005EP1585767A2 Synthetic antibody phage libraries
10/19/2005EP1585766A2 Retargeting
10/19/2005EP1585760A2 Btl-ii nucleic acids, proteins, and antibodies
10/19/2005EP1585547A2 Lymphotoxin beta receptor agents in combination with chemotherapeutic agents
10/19/2005EP1585546A2 Kim-1 antagonists and use to modulate immune system
10/19/2005EP1585545A2 Methods of inducing and maintaining immune tolerance
10/19/2005EP1585539A2 Wnt-1 inhibitory factor-1 (wif-1) molecules and uses thereof
10/19/2005EP1585535A2 Pthrp-derived modulators of smooth muscle proliferation
10/19/2005EP1585477A2 Anti-tnf antibodies, compositions, methods and uses
10/19/2005EP1585433A2 Detection methods
10/19/2005EP1425297A4 Isolation of neural stem cells using gangliosides and other surface markers
10/19/2005EP1392719A4 Forms of prostate specific antigens and methods for their detection
10/19/2005EP1354054B1 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses
10/19/2005EP1353948B1 Soluble cyclic analogues of the beta amyloide peptide
10/19/2005EP1175155A4 Method for reducing a susceptibility to tumor formation induced by 3-deoxyglucosone and precursors thereof
10/19/2005EP1109570B1 Modulation of memory effector t-cells with a cd2 binding agent
10/19/2005EP1104482B1 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
10/19/2005EP1100541B1 Hydrogel for the therapeutic treatment of aneurysms
10/19/2005EP1015583B1 Protein containing an srcr domain
10/19/2005EP1000163B1 Pseudomonas exotoxin a-like chimeric immunogens
10/19/2005EP0846173B1 Use of an anti-interleukin-9 antibody for the preparation of a medicament for the treatment of asthma
10/19/2005EP0771208B1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
10/19/2005EP0768894B1 Multi-stage cascade boosting vaccine
10/19/2005CN1685236A N-11 truncated amyloid-beta monoclonal antibodies, compositions, methods and uses
10/19/2005CN1685064A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
10/19/2005CN1685039A Secreted acid phosphatase (SAPM) is present only in pathogenic mycobacteria and expressed selectively at phagosomal PH
10/19/2005CN1684981A Immunoassays for specific determination of SCCA isoforms
10/19/2005CN1684977A Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer
10/19/2005CN1684974A Pesticidally active proteins and polynucleotides obtainable from paenibacillus species
10/19/2005CN1684708A Anti-NGF antibodies for the treatment of various disorders
10/19/2005CN1684706A Methods and compositions for activating or inhibiting VEGF-D and VEGF-C
10/19/2005CN1684702A Method of treating tumors
10/19/2005CN1684700A Gene differentially expressed in breast and bladder cancer and encoded polypeptides
10/19/2005CN1683526A Histone methyl transferase and its preparing method
10/19/2005CN1683413A Process for preparing anti-hepatitis B virus specific transfer facor by gene engineering process
10/19/2005CN1683412A Monoclonal antibody resisting lily asymptomatic virus and its use
10/19/2005CN1683411A Lefteye flonder lymphocystic virus neutralizing monoclonal antibody and its preparing method
10/19/2005CN1683410A Glycyrrhizic acid anti-body and its preparing method and use
10/19/2005CN1683409A Single strand double specificity anti-body resisting human B cell leucoma
10/19/2005CN1683406A Clonorichis sinensis CDC 42 like protein, its coded nucleic acid and its use
10/19/2005CN1683405A Clonorichis sinensis II 14-3-3 protein, its coded nucleic acid and its use
10/19/2005CN1683404A Clonorichis sinensis ubiquitin homogenetic protein, its coded nucleic acid and its use
10/19/2005CN1683403A Japanese blood fluke cell periodic static agent, its coded nucleic acid and its use
10/19/2005CN1683402A Clonorichis sinensis annexin, its coded nucleic acid and its use
10/19/2005CN1683401A Clonorchis sinensis GTP bindin alpha subunit, its coded nucleic acid and its use
10/19/2005CN1683400A Clonorchis sinensis transport protein, its coded nucleic acid and its use
10/19/2005CN1682682A Hair tension and hardness improving agent
10/19/2005CN1223682C Diagnose test
10/19/2005CN1223609C Coating method in detecting monoclone antibody of rice blast germ process
10/19/2005CN1223608C Caspase-8 interacting proteins
10/19/2005CN1223607C Human calcium ion/calmodulin dependent protein kinase II inhibitory protein and its application
10/19/2005CN1223596C Method and kit for detecting and determining beta -lactam penicillin
10/18/2005US6956110 Genes involved in the molecular paths of tumor suppression and/or resistance to viruses
10/18/2005US6956108 PRO1184 antibodies
10/18/2005US6956107 Antibody, homologues, or analogues or fragments, peptide, or peptidomimetic used as serene protease inhibitor (factor D inhibitor)
10/18/2005US6956104 Proteins for use in the treatment and diagnosis of brain and nervous system disorders
10/18/2005US6956102 Human N-methyl-D-aspartate receptor subunits nucleic acids encoding same and uses therefor
10/18/2005US6955924 Using anti- gamma 2 chain antibodies to inhibit the gamma 2 chain biological activity of said invasive carcinogens.
10/18/2005US6955917 Chromatographic method for high yield purification and viral inactivation of antibodies
10/18/2005US6955900 for complemetary determining regions (CDR) of immunoglobulin heavy/light chains displayed on the surface of filamentous phage particles
10/18/2005US6955899 comprises collagen-like domain; tissue remodeling
10/18/2005US6955894 cytokines; for increasing/decreasing signal transduction; metalloproteases; for treating inflammation during treatment of septic shock, arthritis, and/or multiple sclerosis
10/18/2005US6955884 Nucleotide sequences coding protein for use in the treatment of inflammation, graft rejection, ischemia, asthma, autoimmune disease, diabetes, arthritis, and infection
10/18/2005US6955811 Methods of inhibiting immune response suppression by administering antibodies to OX-2
10/18/2005US6955810 Method for the treatment of inflammatory disorders
10/18/2005US6955717 Crystals and structure of Synagis Fab
10/18/2005US6955625 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/18/2005CA2299504C Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
10/18/2005CA2033640C Vaccines against cancer and infectious diseases
10/13/2005WO2005095981A1 Cancer diagnosis and treatment using anti-robo1 antibody
10/13/2005WO2005095964A2 Methods and compositions for the detection of cervical disease
10/13/2005WO2005095612A1 Gene encoding guanine nucleotide exchange factor and gene product thereof
10/13/2005WO2005095609A1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide
10/13/2005WO2005095598A1 Cancer antigen peptide originating in wt1
10/13/2005WO2005095582A2 Novel cell culture medium supplements
10/13/2005WO2005095461A2 Gold-binding protein and use thereof
10/13/2005WO2005095460A2 Bi-specific antibodies for targeting cells involved in allergic-type reactions, compositions and uses thereof
1 ... 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 ... 1494